1. Budgetary impact of using BPaL for treating extensively drug-resistant tuberculosis. Issue 1 (6th January 2022) Authors: Mulder, Christiaan; Rupert, Stephan; Setiawan, Ery; Mambetova, Elmira; Edo, Patience; Sugiharto, Jhon; Useni, Sani; Malhotra, Shelly; Cook-Scalise, Sarah; Pambudi, Imran; Kadyrov, Abdullaat; Lawanson, Adebola; van den Hof, Susan; Gebhard, Agnes; Juneja, Sandeep; Sohn, Hojoon Journal: BMJ global health Issue: Volume 7:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical Impact of Rapid Drug Susceptibility Testing to Accompany Fluoroquinolone-Containing Universal Tuberculosis Regimens: A Markov Model. (9th December 2019) Authors: Kendall, Emily A; Malhotra, Shelly; Cook-Scalise, Sarah; Dowdy, David W; Denkinger, Claudia M Journal: Clinical infectious diseases Issue: Volume 71:Number 11(2020) Page Start: 2889 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗